Why is Natco Pharma Ltd. ?
- PBT LESS OI(Q) At Rs -12.60 cr has Fallen at -102.3% (vs previous 4Q average)
- PAT(Q) At Rs 133.00 cr has Fallen at -72.6% (vs previous 4Q average)
- NET SALES(Q) Lowest at Rs 474.80 cr
- The technical trend has deteriorated from Mildly Bearish on 03-Apr-25 and has generated -8.12% returns since then
- Multiple factors for the stock are Bearish like MACD, Bollinger Band and KST
- Along with generating -19.55% returns in the last 1 year, the stock has also underperformed BSE 500 in the last 3 years, 1 year and 3 months
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Drugs)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Natco Pharma for you?
High Risk, Low Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
At Rs 810.30 cr has Grown at 39.30%
Highest at 32.29%
Highest at 5.89 times
Highest at Rs 1,562.10 cr
At Rs -12.60 cr has Fallen at -102.3% (vs previous 4Q average
At Rs 133.00 cr has Fallen at -72.6% (vs previous 4Q average
Lowest at Rs 474.80 cr
Lowest at Rs 38.80 cr.
Lowest at 8.17%
is 107.70 % of Profit Before Tax (PBT
Lowest at Rs 7.43
Here's what is working for Natco Pharma
Inventory Turnover Ratio
Cash and Cash Equivalents
Here's what is not working for Natco Pharma
Net Sales (Rs Cr)
PBT less Other Income (Rs Cr)
PAT (Rs Cr)
Net Sales (Rs Cr)
Operating Profit (Rs Cr)
Operating Profit to Sales
PBT less Other Income (Rs Cr)
Non Operating Income to PBT
EPS (Rs)
Non Operating Income